LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 263 of 520
Next
>>
>
6551 to 6575 of 12982 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Normalized Growth Rate Inhibition Value
BT-20	JW-7-24-1	3.33	uM	LJP6	1	B20	72	hr	1334	3061	3955	0.7738	0.6982
BT-20	JW-7-24-1	3.33	uM	LJP6	2	B20	72	hr	1334	3439	3899	0.8820	0.8440
BT-20	JW-7-24-1	3.33	uM	LJP6	3	B20	72	hr	1334	3555	3921	0.9066	0.8777
BT-20	JW-7-24-1	10	uM	LJP6	1	B19	72	hr	1334	1299	3955	0.3284	-0.0171
BT-20	JW-7-24-1	10	uM	LJP6	2	B19	72	hr	1334	1568	3899	0.4021	0.1098
BT-20	JW-7-24-1	10	uM	LJP6	3	B19	72	hr	1334	1614	3921	0.4116	0.1300
BT-20	Dasatinib	0.04	uM	LJP6	1	I06	72	hr	1334	3058	3955	0.7730	0.6971
BT-20	Dasatinib	0.04	uM	LJP6	2	I06	72	hr	1334	2901	3899	0.7440	0.6520
BT-20	Dasatinib	0.04	uM	LJP6	3	I06	72	hr	1334	2781	3921	0.7092	0.6034
BT-20	Dasatinib	0.04	uM	LJP5	1	D06	72	hr	1334	3341	3930	0.8500	0.8019
BT-20	Dasatinib	0.04	uM	LJP5	2	D06	72	hr	1334	3400	4051	0.8393	0.7928
BT-20	Dasatinib	0.04	uM	LJP5	3	D06	72	hr	1334	3624	4117	0.8801	0.8489
BT-20	Dasatinib	0.12	uM	LJP6	1	I05	72	hr	1334	2335	3955	0.5903	0.4288
BT-20	Dasatinib	0.12	uM	LJP6	2	I05	72	hr	1334	2455	3899	0.6296	0.4830
BT-20	Dasatinib	0.12	uM	LJP6	3	I05	72	hr	1334	2411	3921	0.6148	0.4628
BT-20	Dasatinib	0.12	uM	LJP5	1	D05	72	hr	1334	2410	3930	0.6131	0.4611
BT-20	Dasatinib	0.12	uM	LJP5	2	D05	72	hr	1334	2455	4051	0.6060	0.4630
BT-20	Dasatinib	0.12	uM	LJP5	3	D05	72	hr	1334	2392	4117	0.5809	0.4319
BT-20	Dasatinib	0.37	uM	LJP6	1	I04	72	hr	1334	2058	3955	0.5203	0.3182
BT-20	Dasatinib	0.37	uM	LJP6	2	I04	72	hr	1334	1800	3899	0.4616	0.2134
BT-20	Dasatinib	0.37	uM	LJP6	3	I04	72	hr	1334	1461	3921	0.3726	0.0599
BT-20	Dasatinib	0.37	uM	LJP5	1	D04	72	hr	1334	1566	3930	0.3984	0.1080
BT-20	Dasatinib	0.37	uM	LJP5	2	D04	72	hr	1334	1511	4051	0.3730	0.0805
BT-20	Dasatinib	0.37	uM	LJP5	3	D04	72	hr	1334	1713	4117	0.4160	0.1660
BT-20	Dasatinib	1.11	uM	LJP6	1	I03	72	hr	1334	1246	3955	0.3150	-0.0429

|<
<<
Previous
Page 263 of 520
Next
>>
>
6551 to 6575 of 12982 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)